Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function

Camilo Rojas, Ajit G. Thomas, Jesse Alt, Marigo Stathis, Jie Zhang, Edward B. Rubenstein, Silvia Sebastiani, Sergio Cantoreggi, Barbara Slusher

Research output: Contribution to journalArticle

Abstract

Palonosetron is a 5-HT3 receptor antagonist that has demonstrated superiority in preventing both acute and delayed emesis when compared to older first generation 5-HT3 receptor antagonists. The objective of this work was to determine if palonosetron exhibits unique molecular interactions with the 5-HT3 receptor that could provide a scientific rationale for observed clinical efficacy differences. Previously, we showed that palonosetron exhibits allosteric binding and positive cooperativity to the 5-HT3 receptor in contrast to ondansetron and granisetron which exhibit simple bimolecular binding. The present work shows, through several independent experiments, that palonosetron uniquely triggers 5-HT3 receptor internalization and induces prolonged inhibition of receptor function. After 24 h incubation followed by dissociation conditions, [3H]palonosetron remained associated with whole cells but not to cell-free membranes (P <0.001). [3H]Palonosetron's binding to cells was resistant to both protease and acid treatments designed to denature cell surface proteins suggesting that the receptor complex was inside the cells rather than at the surface. Cells pretreated with unlabeled palonosetron subsequently exhibited reduced cell surface 5-HT3 receptor binding. Palonosetron-triggered receptor internalization was visualized by confocal fluorescence microscopy using cells transfected with 5-HT3 receptor fused to enhanced cyan fluorescent protein. In contrast, granisetron and ondansetron showed minimal to no effect on receptor internalization or prolonged inhibition of receptor function. These experiments may provide a pharmacological basis for differences noted in published clinical trials comparing palonosetron to other 5-HT3 receptor antagonists.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalEuropean Journal of Pharmacology
Volume626
Issue number2-3
DOIs
StatePublished - Jan 25 2010

Fingerprint

Receptors, Serotonin, 5-HT3
Serotonin 5-HT3 Receptor Antagonists
Granisetron
Ondansetron
palonosetron
Fluorescence Microscopy
Confocal Microscopy
Vomiting
Membrane Proteins
Peptide Hydrolases
Cell Membrane
Clinical Trials
Pharmacology
Acids

Keywords

  • 5-HT receptor
  • Granisetron
  • Ondansetron
  • Palonosetron
  • Receptor internalization

ASJC Scopus subject areas

  • Pharmacology

Cite this

Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function. / Rojas, Camilo; Thomas, Ajit G.; Alt, Jesse; Stathis, Marigo; Zhang, Jie; Rubenstein, Edward B.; Sebastiani, Silvia; Cantoreggi, Sergio; Slusher, Barbara.

In: European Journal of Pharmacology, Vol. 626, No. 2-3, 25.01.2010, p. 193-199.

Research output: Contribution to journalArticle

Rojas, Camilo ; Thomas, Ajit G. ; Alt, Jesse ; Stathis, Marigo ; Zhang, Jie ; Rubenstein, Edward B. ; Sebastiani, Silvia ; Cantoreggi, Sergio ; Slusher, Barbara. / Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function. In: European Journal of Pharmacology. 2010 ; Vol. 626, No. 2-3. pp. 193-199.
@article{ca2ca977a81a4dd4b3ad8929a628b304,
title = "Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function",
abstract = "Palonosetron is a 5-HT3 receptor antagonist that has demonstrated superiority in preventing both acute and delayed emesis when compared to older first generation 5-HT3 receptor antagonists. The objective of this work was to determine if palonosetron exhibits unique molecular interactions with the 5-HT3 receptor that could provide a scientific rationale for observed clinical efficacy differences. Previously, we showed that palonosetron exhibits allosteric binding and positive cooperativity to the 5-HT3 receptor in contrast to ondansetron and granisetron which exhibit simple bimolecular binding. The present work shows, through several independent experiments, that palonosetron uniquely triggers 5-HT3 receptor internalization and induces prolonged inhibition of receptor function. After 24 h incubation followed by dissociation conditions, [3H]palonosetron remained associated with whole cells but not to cell-free membranes (P <0.001). [3H]Palonosetron's binding to cells was resistant to both protease and acid treatments designed to denature cell surface proteins suggesting that the receptor complex was inside the cells rather than at the surface. Cells pretreated with unlabeled palonosetron subsequently exhibited reduced cell surface 5-HT3 receptor binding. Palonosetron-triggered receptor internalization was visualized by confocal fluorescence microscopy using cells transfected with 5-HT3 receptor fused to enhanced cyan fluorescent protein. In contrast, granisetron and ondansetron showed minimal to no effect on receptor internalization or prolonged inhibition of receptor function. These experiments may provide a pharmacological basis for differences noted in published clinical trials comparing palonosetron to other 5-HT3 receptor antagonists.",
keywords = "5-HT receptor, Granisetron, Ondansetron, Palonosetron, Receptor internalization",
author = "Camilo Rojas and Thomas, {Ajit G.} and Jesse Alt and Marigo Stathis and Jie Zhang and Rubenstein, {Edward B.} and Silvia Sebastiani and Sergio Cantoreggi and Barbara Slusher",
year = "2010",
month = "1",
day = "25",
doi = "10.1016/j.ejphar.2009.10.002",
language = "English (US)",
volume = "626",
pages = "193--199",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function

AU - Rojas, Camilo

AU - Thomas, Ajit G.

AU - Alt, Jesse

AU - Stathis, Marigo

AU - Zhang, Jie

AU - Rubenstein, Edward B.

AU - Sebastiani, Silvia

AU - Cantoreggi, Sergio

AU - Slusher, Barbara

PY - 2010/1/25

Y1 - 2010/1/25

N2 - Palonosetron is a 5-HT3 receptor antagonist that has demonstrated superiority in preventing both acute and delayed emesis when compared to older first generation 5-HT3 receptor antagonists. The objective of this work was to determine if palonosetron exhibits unique molecular interactions with the 5-HT3 receptor that could provide a scientific rationale for observed clinical efficacy differences. Previously, we showed that palonosetron exhibits allosteric binding and positive cooperativity to the 5-HT3 receptor in contrast to ondansetron and granisetron which exhibit simple bimolecular binding. The present work shows, through several independent experiments, that palonosetron uniquely triggers 5-HT3 receptor internalization and induces prolonged inhibition of receptor function. After 24 h incubation followed by dissociation conditions, [3H]palonosetron remained associated with whole cells but not to cell-free membranes (P <0.001). [3H]Palonosetron's binding to cells was resistant to both protease and acid treatments designed to denature cell surface proteins suggesting that the receptor complex was inside the cells rather than at the surface. Cells pretreated with unlabeled palonosetron subsequently exhibited reduced cell surface 5-HT3 receptor binding. Palonosetron-triggered receptor internalization was visualized by confocal fluorescence microscopy using cells transfected with 5-HT3 receptor fused to enhanced cyan fluorescent protein. In contrast, granisetron and ondansetron showed minimal to no effect on receptor internalization or prolonged inhibition of receptor function. These experiments may provide a pharmacological basis for differences noted in published clinical trials comparing palonosetron to other 5-HT3 receptor antagonists.

AB - Palonosetron is a 5-HT3 receptor antagonist that has demonstrated superiority in preventing both acute and delayed emesis when compared to older first generation 5-HT3 receptor antagonists. The objective of this work was to determine if palonosetron exhibits unique molecular interactions with the 5-HT3 receptor that could provide a scientific rationale for observed clinical efficacy differences. Previously, we showed that palonosetron exhibits allosteric binding and positive cooperativity to the 5-HT3 receptor in contrast to ondansetron and granisetron which exhibit simple bimolecular binding. The present work shows, through several independent experiments, that palonosetron uniquely triggers 5-HT3 receptor internalization and induces prolonged inhibition of receptor function. After 24 h incubation followed by dissociation conditions, [3H]palonosetron remained associated with whole cells but not to cell-free membranes (P <0.001). [3H]Palonosetron's binding to cells was resistant to both protease and acid treatments designed to denature cell surface proteins suggesting that the receptor complex was inside the cells rather than at the surface. Cells pretreated with unlabeled palonosetron subsequently exhibited reduced cell surface 5-HT3 receptor binding. Palonosetron-triggered receptor internalization was visualized by confocal fluorescence microscopy using cells transfected with 5-HT3 receptor fused to enhanced cyan fluorescent protein. In contrast, granisetron and ondansetron showed minimal to no effect on receptor internalization or prolonged inhibition of receptor function. These experiments may provide a pharmacological basis for differences noted in published clinical trials comparing palonosetron to other 5-HT3 receptor antagonists.

KW - 5-HT receptor

KW - Granisetron

KW - Ondansetron

KW - Palonosetron

KW - Receptor internalization

UR - http://www.scopus.com/inward/record.url?scp=70649090118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70649090118&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2009.10.002

DO - 10.1016/j.ejphar.2009.10.002

M3 - Article

VL - 626

SP - 193

EP - 199

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -